File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Eriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiol-containing antioxidant systems and downstream signalling pathways

TitleEriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiol-containing antioxidant systems and downstream signalling pathways
Authors
KeywordsApoptosis
Eriocalyxin B
Pancreatic cancer
Reactive oxygen species
Thiols
Issue Date2014
Citation
Current Molecular Medicine, 2014, v. 14, n. 5, p. 673-689 How to Cite?
AbstractThiol-containing antioxidant systems play an important role in regulating cellular redox homeostasis. Several anti-cancer agents act by targeting these systems by inducing the production of reactive oxygen species (ROS). Our earlier studies have shown that Eriocalyxin B (EriB), a diterpenoid isolated from Isodon eriocalyx, possesses anti-pancreatic tumour activities in vitro and in vivo. The present study further demonstrated that only thiol-containing antioxidants, N-acetylcysteine (NAC) or dithiothreitol (DTT), inhibited EriB-induced cytotoxicity and apoptosis. EriB suppressed the glutathione and thioredoxin antioxidant systems, thus increasing the intracellular ROS levels and regulating the MAPK, NFκB pathways. Treatment with EriB depleted the intracellular thiol-containing proteins in CAPAN-2 cells. In vivo studies also showed that EriB treatment (2.5 mg/kg) reduced the pancreatic tumour weights significantly in nude mice with increased superoxide levels. Taken together, our results shed important new light on the molecular mechanisms of EriB acting as an apoptogenic agent and its therapeutic potential for pancreatic cancer. © 2014 Bentham Science Publishers.
Persistent Identifierhttp://hdl.handle.net/10722/343156
ISSN
2023 Impact Factor: 2.2
2023 SCImago Journal Rankings: 0.531

 

DC FieldValueLanguage
dc.contributor.authorLi, L.-
dc.contributor.authorYue, G. G.L.-
dc.contributor.authorPu, J. X.-
dc.contributor.authorSun, H. D.-
dc.contributor.authorFung, K. P.-
dc.contributor.authorLeung, P. C.-
dc.contributor.authorHan, Q. B.-
dc.contributor.authorLau, C. B.S.-
dc.contributor.authorLeung, P. S.-
dc.date.accessioned2024-05-10T09:05:54Z-
dc.date.available2024-05-10T09:05:54Z-
dc.date.issued2014-
dc.identifier.citationCurrent Molecular Medicine, 2014, v. 14, n. 5, p. 673-689-
dc.identifier.issn1566-5240-
dc.identifier.urihttp://hdl.handle.net/10722/343156-
dc.description.abstractThiol-containing antioxidant systems play an important role in regulating cellular redox homeostasis. Several anti-cancer agents act by targeting these systems by inducing the production of reactive oxygen species (ROS). Our earlier studies have shown that Eriocalyxin B (EriB), a diterpenoid isolated from Isodon eriocalyx, possesses anti-pancreatic tumour activities in vitro and in vivo. The present study further demonstrated that only thiol-containing antioxidants, N-acetylcysteine (NAC) or dithiothreitol (DTT), inhibited EriB-induced cytotoxicity and apoptosis. EriB suppressed the glutathione and thioredoxin antioxidant systems, thus increasing the intracellular ROS levels and regulating the MAPK, NFκB pathways. Treatment with EriB depleted the intracellular thiol-containing proteins in CAPAN-2 cells. In vivo studies also showed that EriB treatment (2.5 mg/kg) reduced the pancreatic tumour weights significantly in nude mice with increased superoxide levels. Taken together, our results shed important new light on the molecular mechanisms of EriB acting as an apoptogenic agent and its therapeutic potential for pancreatic cancer. © 2014 Bentham Science Publishers.-
dc.languageeng-
dc.relation.ispartofCurrent Molecular Medicine-
dc.subjectApoptosis-
dc.subjectEriocalyxin B-
dc.subjectPancreatic cancer-
dc.subjectReactive oxygen species-
dc.subjectThiols-
dc.titleEriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiol-containing antioxidant systems and downstream signalling pathways-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.2174/1566524014666140603102459-
dc.identifier.pmid24894173-
dc.identifier.scopuseid_2-s2.0-84904048819-
dc.identifier.volume14-
dc.identifier.issue5-
dc.identifier.spage673-
dc.identifier.epage689-
dc.identifier.eissn1875-5666-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats